# US 2019/0170750 A1 · Method for the Detection of an IgM Antibody Specific for a Flavivirus in a Sample

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0170750 A1
- Document ID: US20190170750A1
- Status: Published application
- Kind: A1
- Application number: 16/307,710
- Filed: 2017-06-02
- Published: 2019-06-06
- Earliest claimed: 2016-06-06
- Assignees: Medizinische Universität Wien
- Applicants: Medizinische UniversitäT Wien
- Inventors: Franz X. HEINZ; Karin STIASNY
- Web page: https://patentgrep.com/patent/US20190170750A1

## CPC

- G01N 33/56983: {Viruses}
- G01N 2333/185: Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
- G01N 2469/20: Detection of antibodies in sample from host which are directed against antigens from microorganisms
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Disclosed is a method for the detection of an IgM antibody specific for a flavivirus in a sample, comprising the steps of (a) contacting the sample with a solid support comprising immobilised IgM-binding molecules, (b) allowing binding of IgM antibodies in the sample to the IgM binding molecules on the solid support so that the IgM antibodies are also immobilised on the solid support, and (c) detecting IgM antibodies specific for a flavivirus by allowing binding of a complex comprising (i) an antiparallel dimer of soluble flavivirus Protein E (sE) and (ii) a marker and identifying the binding of the complex to the specific flavivirus IgM antibody by detecting the marker; and a kit suitable for performing the method.

## Claims

### Claim 1

A method for the detection of an IgM antibody specific for a flavivirus in a sample, comprising:
(a) contacting the sample with a solid support comprising immobilised IgM-binding molecules,
(b) allowing binding of IgM antibodies in the sample to the IgM binding molecules on the solid support so that the IgM antibodies are also immobilised on the solid support, and
(c) premixing an antiparallel dimer of soluble flavivirus Protein E (sE) with a marker for formation of a complex comprising the sE dimer and the marker, wherein the antiparallel dimer of sE comprises a tag and wherein the tag links the marker to the antiparallel dimer of sE, and
(d) detecting IgM antibodies specific for a flavivirus by allowing binding of the preformed complex
and identifying the binding of the complex to the specific flavivirus IgM antibody by detecting the marker.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the IgM-binding molecules are anti-IgM antibodies or IgM-binding fragments thereof.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the flavivirus is selected from group tick-borne encephalitis virus (TBEV) or dengue virus (DENV)

### Claim 4 (depends on 1)

The method according to claim 1, wherein the sample is a serum or plasma sample, or a cerebrospinal fluid (CSF) sample.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the tag is selected from Strep-tag or His-tag.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the marker is selected from an affinity marker, a fluorescence marker, a radioactive marker, a nucleic acid marker, a chromogenic marker, a luminescence marker, a magnetic marker, or combinations thereof.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the complex comprises a labelled antibody and/or a Strep-tag binding protein.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the solid support is a microtiter plate or other plastic containers or surfaces, a biological microchip, a bead, a disc, a magnetic particle, a fiber optic sensor, a glass slide, or a membrane, preferably a nitrocellulose membrane, a polytetrafluorethylene membrane, a cellulose acetate membrane or a cellulose nitrate membrane.

### Claim 9 (depends on 1)

The method according to claim 1, wherein detecting the marker comprises the addition of further substances thereby generating a signal or activating the marker to elicit a signal and measuring the signal.

### Claim 10 (depends on 1)

The method according to claim 1, wherein sE of a flavivirus distantly related to the important human pathogenic flaviviruses is applied as a control.

### Claim 11 (depends on 1)

The method according to claim 1, wherein the method is performed in an automated system.

### Claim 12 (depends on 1)

A kit comprising:
a solid support comprising immobilised IgM-binding molecules; and
a complex comprising:
(i) an antiparallel dimer of soluble flavivirus Protein E (sE); and
(ii) a marker, for performing the method according to claim 1.

### Claim 13 (depends on 12)

The kit of claim 12, further defined as comprising means to detect the marker.

### Claim 14 (depends on 12)

The kit of claim 12, further defined as comprising an automated detection system.

### Claim 15 (depends on 12)

The kit of claim 12, wherein at least the solid support and/or the complex and/or the sE and the marker are packed in a sterile wrap.

### Claim 16 (depends on 3)

The method of claim 3, wherein the flavivirus is selected from DENV serotype 1 (DEN1), DENV serotype 2 (DEN2), DENV serotype 3 (DEN3), and DENV serotype 4 (DEN4), and Zika virus (ZV).

### Claim 17 (depends on 7)

The method of claim 7, wherein the complex comprises a labelled antibody specific for a tag of the antiparallel dimer of sE and/or a Strep-tag binding protein comprising a marker further defined as an affinity marker, a fluorescence marker, a radioactive marker, a nucleic acid marker, a chromogenic marker, a luminescence marker, a magnetic marker, or combination thereof.

### Claim 18 (depends on 10)

The method of claim 10, wherein the control is sE of Rio Bravo, Modoc, Yokose, Entebbe bat, Barkedji, or Lammi viruses.

### Claim 19 (depends on 13)

The kit of claim 13, further defined as comprising means for detecting an affinity marker, a fluorescence marker, a radioactive marker, a chromogenic marker, a luminescence marker, or a magnetic marker.

### Claim 20 (depends on 14)

The kit of claim 14, wherein the automated detection system is further defined as comprising a sample conveying device, a detection device, a computer processing unit and/or a display for displaying the signal from the detection unit processed by computer software programs executed with the computer processing unit.
